Virginia recalls

Medline Convenience Kits (Model SUT13710) contain Lidocaine Ampules that were subject to a recall by the manufacturer Huons Co., Ltd. due to quality issues found during an FDA inspection of their manufacturing facility. About 176 kits were distributed nationwide.

Medline's Imaging Biopsy Tray (Model DYNDH1068) and Breast Biopsy Pack (Model PHS234706I) contain lidocaine ampules that were identified as defective during an FDA manufacturing inspection. The ampules were supplied by Huons Co., Ltd. and may not meet quality standards. Approximately 40 kits are affected nationwide.

Medline Convenience Kits containing Huons Lidocaine HCL Injection ampules are being recalled due to quality issues found during an FDA manufacturing inspection. The affected kits include two introducer models (6F and 9F) distributed nationwide. No injuries have been reported.

Medline Industries is recalling three models of medical convenience kits that contain Lidocaine Ampules manufactured by Huons Co., Ltd. The ampules were recalled due to quality issues found during an FDA inspection of the manufacturing facility. The affected kits are used in radiology, pain management, and endovenous procedures.

Medline is recalling 34 different models of central line insertion kits that contain lidocaine ampules manufactured by Huons Co., Ltd. The ampules were found to have quality issues during an FDA inspection of the manufacturer's facility. Approximately 967 kits are affected.

Medline's Convenience Kits (Model DYNJRA1590) contain Lidocaine Ampules that were recalled by the manufacturer, Huons Co., Ltd., due to quality issues found during an FDA manufacturing inspection. About 270 kits were distributed nationwide.

Medline distributed convenience kits containing lidocaine ampules manufactured by Huons Co., Ltd. The FDA identified quality issues with the lidocaine during a manufacturing inspection of Huons' facility. The affected kits are used for epidural anesthesia and pain management procedures.

Medline's arterial access and line insertion kits contain Lidocaine ampules from Huons Co., Ltd. that have quality defects. The defects were identified during an FDA inspection of the Lidocaine manufacturer's facility. The affected kits were distributed nationwide.

Certain coaxial breathing circuit sets used with Hamilton Medical ventilators (models C1, T1, and MR1) may have expiratory valve membranes that stick to the valve body. This defect is not always detectable before use and can trigger an "exhalation obstructed" alarm during ventilation, potentially leading to inadequate ventilation and oxygen desaturation in patients.

Nara Organics Whole Milk Organic Infant Formula in two sizes may be contaminated with Clostridium botulinum, a bacterium that can cause botulism. The contamination was identified in specific lot codes with use-by dates between March 2027 and February 2028. No illnesses have been reported.

MorningStar Farms Hot & Spicy Sausage Patties (8 oz. bags, UPC 028989100948) may contain plastic material. The affected products have "Best If Used By" dates of July 5, 6, or 7, 2027 and were distributed nationwide.

MorningStar Farms Buffalo Chik'n Nuggets (10.5 oz bags, UPC 028989101105) may contain plastic material. The affected products have a "Best If Used By" date of July 7 or 8, 2027. No injuries have been reported.

MOGO Pure Moringa Oleifera capsules may be contaminated with Salmonella Typhimurium. The contamination was discovered during testing. Affected bottles were sold online through Amazon, eBay, Etsy, and mogomiranga.com.

Cipla USA is recalling Cinacalcet Hydrochloride 90 mg tablets (lot 5PB0563, expiring 4/30/2027) because they contain elevated levels of N-nitroso-cinacalcet, a potentially harmful impurity that exceeds acceptable daily intake limits. This is a manufacturing quality issue.

Cipla USA is recalling certain batches of Cinacalcet Hydrochloride 60 mg tablets because they contain N-nitroso-cinacalcet, a chemical impurity, at levels above the FDA's acceptable daily intake. The affected lots were distributed nationwide. No injuries have been reported.

Cipla USA is recalling specific lots of Cinacalcet Hydrochloride 30 mg tablets because they contain elevated levels of N-nitroso-cinacalcet, a manufacturing impurity that exceeds FDA safety limits. The affected bottles were distributed nationwide.

Lannett Company distributed amphetamine extended-release capsules that contained only immediate-release pellets but were labeled as extended-release. This labeling error could result in incorrect dosing and medication timing for patients who depend on the extended-release formulation.

Asclemed USA Inc. is recalling Lidocaine HCl Injection USP 1% in 5 mL single-dose ampules due to lack of assurance of sterility. The affected lots were distributed nationwide. This is a precautionary measure to prevent potential infection risk from non-sterile product.

Asclemed USA Inc. is recalling specific lots of Accucaine, a lidocaine injection used for local anesthesia, because the manufacturer cannot guarantee the product is sterile. This affects multiple lot numbers distributed nationwide.

Accord Healthcare is recalling one lot of levothyroxine sodium 300 mcg tablets because they may contain less active ingredient than labeled. This means the medication may not work as intended for patients who need it to manage thyroid conditions.

Lupin Pharmaceuticals is recalling multiple lots of prednisolone acetate ophthalmic suspension 1% (an anti-inflammatory eye drop) due to the presence of a foreign substance in some bottles. The affected lots were distributed nationwide. No injuries have been reported.

Accord BioPharma is recalling one lot of IMULDOSA (ustekinumab-srlf) injection due to lack of assurance that the product is sterile. The affected lot may not meet sterility standards required for injectable medications. No injuries have been reported.

BD ChloraPrep CLear applicators intended for further processing and sterilization were distributed directly to customers without being sterilized first. The product is a skin antiseptic used before medical procedures. No injuries have been reported.

BD ChloraPrep CLear, a chlorhexidine-based skin antiseptic solution in single-use applicators, was distributed without proper sterilization. Unsterilized applicators intended for further processing were mistakenly sent to customers outside the intended distribution channel. This affects 18,000 units across multiple lot numbers distributed nationwide.

BD ChloraPrep Scrub Teal applicators intended for further processing and sterilization were mistakenly distributed as finished sterile products. The affected applicators may not meet sterility standards required for safe use in medical settings.

BD ChloraPrep Scrub Teal applicators intended for further processing and sterilization were distributed to customers without having been sterilized. The unsterilized applicators reached customers outside the intended distribution channel. About 1,200 units are affected.

BD ChloraPrep Hi-Lite Orange skin antiseptic applicators were distributed without proper sterilization. These units were intended for further processing and sterilization before use, but were instead sent directly to customers. This creates a risk of infection if the applicators are used as distributed.

BD ChloraPrep Hi-Lite Orange applicators intended for further sterilization before use were mistakenly distributed directly to customers without undergoing the required sterilization process. These applicators are used to prepare skin before medical procedures and must be sterile to be safe. The recall affects specific lot numbers distributed nationwide.

CareFusion distributed unsterilized ChloraPrep FREPP applicators (chlorhexidine gluconate and isopropyl alcohol solution) to customers outside their intended distribution channel. These applicators were meant for further processing and sterilization before use, but were shipped to end users without that sterilization step, creating a risk of infection if used on patients.

BD ChloraPrep Clear applicators (a skin-prep solution containing chlorhexidine and isopropyl alcohol) were distributed without proper sterilization. These applicators were intended to be sterilized before sale but were sent to customers in an unsterilized state. The affected products are in 3 ml applicator packs, with multiple lot numbers expiring between June 2026 and February 2029.